August 30, 2012
A judge overseeing a long-running pay-for-delay dispute brought by the Federal Trade Commission and others against Cephalon Inc. stayed the cases Wednesday over the objections of the plaintiffs until the U.S. Supreme Court decides whether to hear another case on the underlying antitrust issue.
July 05, 2011
A Pennsylvania federal judge on Tuesday ordered Barr Laboratories Inc. — one of four generics makers accused of taking payments from Cephalon Inc. to stay out of the market for Provigil — to provide direct purchaser plaintiffs with communications it had with suppliers regarding financial details of settlements in several patent infringement cases.
November 05, 2010
A federal judge has rejected Jabo's Pharmacy Inc.'s bid to remand to state court its class action accusing Cephalon Inc. and generic-drug makers including Barr Pharmaceuticals Inc. of conspiring to keep a generic version of narcolepsy drug Provigil off the market.
October 19, 2010
Tennessee-based Jabo's Pharmacy Inc. has moved to remand to state court its lawsuit accusing Cephalon Inc. and several generics makers — including Barr Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. — of conspiring to keep a generic version of narcolepsy drug Provigil off the market.
October 05, 2010
A federal judge has consolidated three lawsuits, one a class action, accusing Cephalon Inc. and several generics makers — including Barr Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. — of conspiring to keep a generic version of narcolepsy drug Provigil off the market.